Jump Financial LLC Purchases Shares of 107,197 Orthofix Medical Inc. (NASDAQ:OFIX)

Jump Financial LLC purchased a new position in Orthofix Medical Inc. (NASDAQ:OFIXFree Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 107,197 shares of the medical device company’s stock, valued at approximately $1,445,000. Jump Financial LLC owned approximately 0.29% of Orthofix Medical as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of the business. Swiss National Bank boosted its stake in Orthofix Medical by 1.3% in the 3rd quarter. Swiss National Bank now owns 76,400 shares of the medical device company’s stock worth $983,000 after purchasing an additional 1,000 shares in the last quarter. Gladius Capital Management LP lifted its stake in shares of Orthofix Medical by 55.2% during the fourth quarter. Gladius Capital Management LP now owns 2,841 shares of the medical device company’s stock worth $38,000 after buying an additional 1,010 shares during the period. Gamco Investors INC. ET AL grew its holdings in shares of Orthofix Medical by 1.4% during the third quarter. Gamco Investors INC. ET AL now owns 91,400 shares of the medical device company’s stock valued at $1,175,000 after buying an additional 1,300 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Orthofix Medical by 30.4% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,516 shares of the medical device company’s stock valued at $101,000 after acquiring an additional 1,752 shares during the period. Finally, Mutual of America Capital Management LLC increased its position in shares of Orthofix Medical by 2.2% in the 3rd quarter. Mutual of America Capital Management LLC now owns 161,376 shares of the medical device company’s stock valued at $2,075,000 after acquiring an additional 3,498 shares during the period. Hedge funds and other institutional investors own 89.76% of the company’s stock.

Orthofix Medical Stock Performance

Shares of OFIX stock opened at $15.37 on Thursday. Orthofix Medical Inc. has a 52-week low of $9.57 and a 52-week high of $21.60. The company has a quick ratio of 1.19, a current ratio of 2.65 and a debt-to-equity ratio of 0.23. The stock has a market cap of $574.99 million, a PE ratio of -4.55 and a beta of 1.06. The business has a 50-day simple moving average of $13.83 and a 200-day simple moving average of $13.17.

Orthofix Medical (NASDAQ:OFIXGet Free Report) last announced its quarterly earnings results on Tuesday, March 5th. The medical device company reported ($0.59) earnings per share for the quarter, beating the consensus estimate of ($0.60) by $0.01. Orthofix Medical had a negative return on equity of 14.24% and a negative net margin of 16.64%. The company had revenue of $200.42 million during the quarter. On average, equities analysts expect that Orthofix Medical Inc. will post -1.43 EPS for the current year.

Analyst Ratings Changes

A number of analysts have commented on the company. Roth Capital raised Orthofix Medical from a “neutral” rating to a “buy” rating in a research report on Wednesday, May 8th. StockNews.com raised Orthofix Medical from a “sell” rating to a “hold” rating in a report on Wednesday, May 8th. Roth Mkm upgraded shares of Orthofix Medical from a “neutral” rating to a “buy” rating and increased their price target for the stock from $15.00 to $20.00 in a report on Wednesday, May 8th. Finally, JMP Securities reissued a “market perform” rating on shares of Orthofix Medical in a research report on Monday, April 22nd. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $18.00.

Check Out Our Latest Report on OFIX

Orthofix Medical Company Profile

(Free Report)

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.

Featured Stories

Institutional Ownership by Quarter for Orthofix Medical (NASDAQ:OFIX)

Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.